In vitro and in vivo susceptibility of Leishmania major to some medicinal plants

In vitro and in vivo susceptibility of Leishmania major to some medicinal plants

Objective: To evaluate the efficacy of some medicinal plants and systemic glucantime in a comparative manner against the causative agent of cutaneous leishmaniasis both in vitro and in BALB/c mice. Methods: For in vivo testing, inbred mice were challenged with Leishmania major parasites and the resu...

Full description

Bibliographic Details
Main Authors:	Fatemeh Maleki, Mitra Zarebavani, Mehdi Mohebali, Mohammad Saaid Dayer, Fateme Hajialiani, Fatemeh Tabatabaie
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2017-01-01
Series:	Asian Pacific Journal of Tropical Biomedicine
Subjects:	Leishmaniasis Glucantime Plant extracts Mice Medicinal plants
Online Access:	http://www.sciencedirect.com/science/article/pii/S2221169116302477

Similar Items

Biodistribution of meglumine antimoniate in healthy and Leishmania (Leishmania) infantum chagasi-infected BALB/c mice
by: Samanta Etel Treiger Borborema, et al.
Published: (2013-08-01)

Calazar: Estudio de 18 pacientes en Brasil Kala-azar. Study of 18 patients in Brazil
by: Moisés Morejón García, et al.
Published: (2006-06-01)

Immunotherapy Using Autoclaved L. Major Antigens and M. Vaccae with Meglumine Antimoniate, for the Treatment of Experimental Canine Visceral Leishmaniasis
by: Sh Jamshidi, et al.
Published: (2011-09-01)

Immunotherapy Using Autoclaved L. major Antigens and M. vaccae with Meglumine Antimoniate, for the Treatment of Experimental Canine Visceral Leishmaniasis
by: Sh Jamshidi, et al.
Published: (2011-09-01)

The Evaluation of Intralesional Glucantime and Cryotherapy plus Intralesional Glucantime Therapeutic Efficacy on Zoonotic Cutaneous Leishmaniasis: A Randomized Clinical Trial
by: Abedin Saghafipour, et al.
Published: (2017-12-01)

A Comparetaive Study on Glucantime and Oral Terbinafine along with Systemic Glucantime on Cutaneous Leishmaniasis
by: Saba Ebrahimian, et al.
Published: (2011-03-01)

The efficacy of Achilles millefolium topical gel along with intralesional injection of glucantime in the treatment of acute cutaneous leishmaniasis major
by: Fariba Jaffary, et al.
Published: (2014-01-01)

Evaluation of synergistic therapeutic effect of shark cartilage extract with artemisinin and glucantime on visceral leishmaniasis in BALB/c mice
by: Soheila Molaie, et al.
Published: (2019-02-01)

Visceral and cutaneous leishmaniasis in urban area of cartagena: a case report
by: Pinzón-Redondo Hernando, et al.
Published: (2012-06-01)

PERILESIONAL INFILTRATION OF GLUCANTIME AND LIDOCAINE FOR TREATMENT OF LEISHMANIASIS
by: Reyes Alirio Torres, et al.
Published: (2000-05-01)

Comparison between intralesional glucantime injection and cryotherapy in papular cutaneous leishmaniasis
by: Yazdanpanah MJ, et al.
Published: (2006-10-01)

Visceral leishmaniasis in children
by: mandana Rafeey, et al.
Published: (2005-02-01)

Comparison of Th1 and Th2 Responses in Non-Healing and Healing Patients with Cutaneous Leishmaniasis
by: Maryam Shahi, et al.
Published: (2013-05-01)

HISTORICAL SERIES OF PATIENTS WITH VISCERAL LEISHMANIASIS TREATED WITH MEGLUMINE ANTIMONIATE IN A HOSPITAL FOR TROPICAL DISEASES, MACEIÓ-AL, BRAZIL
by: Lindon Johoson Diniz Silveira, et al.
Published: (2015-02-01)

Comparison of Thymus vulgaris (Thyme), Achillea millefolium (Yarrow) and propolis hydroalcoholic extracts versus systemic glucantime in the treatment of cutaneous leishmaniasis in balb/c mice
by: M.A. Nilforoushzadeh, et al.
Published: (2008-11-01)

In Vitro Study of Leishmanicidal Activity of Biogenic Selenium Nanoparticles against Iranian Isolate of Sensitive and Glucantime-Resistant Leishmania tropica
by: Hossein Mahmoudvand, et al.
Published: (2014-12-01)

Treatment of Glucantim™-Resistant Cutaneous Leishmaniasis Using Combination Therapy of Allopurinol and Trichloroacetic Acid (TCA) 50%; Report of Three Cases
by: Giti Sadeghian, et al.
Published: (2017-01-01)

The Effect of Local Allergic Reaction to Intralesional Glucantime on Recovery Course of Cutaneous Leishmaniasis
by: Saman Afkhami-Ardakani, et al.
Published: (2020-04-01)

The Efficacy of Achillea Millefolium Topical Gel Along with Intralesional Injection of Glucantime in the Treatment of Acute Cutaneous Leishmaniasis
by: Fariba Jaffary, et al.
Published: (2012-03-01)

Comparing the Effects of Topical Miltefosine and Glucantime in Treatment of Cutaneous Leishmaniasis
by: Ali Asilian, et al.
Published: (2014-03-01)

Basal cell carcinoma superimposed on a cutaneous leishmaniasis lesion in an immunocompromised patient
by: Ali Asilian, et al.
Published: (2012-01-01)

Decreased effect of glucantime in cutaneous leishmaniasis complicated with secondary bacterial infection
by: G Sadeghian, et al.
Published: (2011-01-01)

Niosomal formulation of amphotericin B alone and in combination with glucantime: In vitro and in vivo leishmanicidal effects
by: Mahshid Mostafavi, et al.
Published: (2019-08-01)

Effective materials of medicinal plants for leishmania treatment in vivo environment
by: Tahereh Zadeh Mehrizi, et al.
Published: (2020-06-01)

Ursolic Acid Potentializes Conventional Therapy in Experimental Leishmaniasis
by: Jéssica Adriana Jesus, et al.
Published: (2020-10-01)

Leishmanicidal and Cytotoxic Activity of Algerian Medicinal Plants on Leishmania major and Leishmania infantum
by: Naouel Eddaikra, et al.
Published: (2019-07-01)

Clinical and laboratory evaluation of cured and non-cured patients with cutaneous leishmaniasis treated by Glucantime
by: F Ezatkhah, et al.
Published: (2019-01-01)

Leishmaniose cutanée: aspects cliniques et thérapeutiques à propos de 40 cas
by: Fatima-Zahra Agharbi, et al.
Published: (2020-02-01)

The Skin Side Effects of Topical Glucantime in Patients with Cutaneous Leishmaniasis
by: Mohammad Ali Nilforoushzadeh, et al.
Published: (2015-08-01)

Immunopathology of american cutaneous leishmaniasis. Modulation of MHC class II gene products by Keratinocytes before and after glucantime therapy
by: Claude Pirmez, et al.
Published: (1990-06-01)

Novel methods for the encapsulation of meglumine antimoniate into liposomes
by: F. Frézard, et al.
Published: (2000-07-01)

Fe3O4@Bio-MOF Nanoparticles Combined with Artemisinin, Glucantime®, or Shark Cartilage Extract on Iranian Strain of Leishmania major (MRHO/IR/75/ER): An In-Vitro and In-Vivo Study
by: Fatemeh‌‌‌‌ GHAFARIFAR, et al.
Published: (2020-12-01)

Comparison of intralesional two percent zinc sulfate and glucantime injection in treatment of acute cutaneous leishmaniasis
by: Masoud Maleki, et al.
Published: (2012-01-01)

A Comparison of the Effects of Topical Injection of Glucantime Plus Glycolic Acid 70% and Salicylic Acid 20% with Topical Injection of Glucantime Alone in the Treatment of Acute Cutaneous Leishmaniasis
by: Mohammad Ali Nilforoushzadeh, et al.
Published: (2017-04-01)

Factors affecting the antimonial treatment duration rate in patients with cutaneous leishmaniasis: survival analysis model
by: Amir Hamta, et al.
Published: (2020-09-01)

Comparison between Combination Therapy of Oral Terbinafine and Cryotherapy versus Systemic Meglumine Antimoniate and Cryotherapy in Cutaneous Leishmaniasis: A Randomized Clinical Trial
by: Saeedeh Farajzadeh, et al.
Published: (2015-03-01)

ALTERAÇÕES LABORATORIAIS E EFEITOS ADVERSOS NO TRATAMENTO DA LEISHMANIOSE VISCERAL: HOSPITAL - ARAGUAÍNA-TO
by: Tobias, Célia Alves dos Santos
Published: (2016)

In vitro and in vivo activities of Peganum harmala extract against Leishmania major
by: Parvaneh Rahimi-Moghaddam, et al.
Published: (2011-01-01)

Report of 103 cases of visceral Leishmaniasis
by: Tabatabaei P
Published: (1999-07-01)

Comparison of Proteome Profiling of Two Sensitive and Resistant Field Iranian Isolates of Leishmania major to Glucantime® by 2- Dimensional Electrophoresis
by: Mehdi Zarean, et al.
Published: (2015-03-01)